Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Capacity and capability of the RENEB network for large-scale radiological and nuclear emergencies: survey results 2025.

Created on 07 Aug 2026

Authors

Jayne Moquet, Stephen Barnard, Joan-Francesc Barquinero, Martin Bucher, Ulrike Kulka, Juan S Martinez, Matthias Port, Andrzej Wojcik, Ursula Oestreicher

Published in

International journal of radiation biology. Pages 1-9. Aug 07, 2026. Epub Aug 07, 2026.

Abstract

Since 2017, the RENEB network (Running the European Network of Biological and Retrospective Physical Dosimetry) is a group of specialized laboratories that can provide mutual assistance in individual dose estimation by biological and retrospective physical dosimetry for large-scale radiological or nuclear emergencies in Europe and beyond. To ensure the operability of RENEB, Working Group 'Infrastructures', regularly produce a survey to update partners contact details, collect information on laboratories emergency capacity/capabilities and sample transport.
An online survey was developed and distributed to RENEB members and completed in May 2025.
Replies were received from scientists working in 29 institutes and provide a clear picture of the RENEB network's capacity and capability.
The data collected gives reassurance that RENEB is ready to react to a large-scale radiological event, as well as giving key information about operational aspects which will be essential during an emergency.

PMID:
42566237
Bibliographic data and abstract were imported from PubMed on 07 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement